SlideShare a Scribd company logo
Uveitis Global Clinical Trials Review, H1, 2015
Uveitis Global Clinical Trials Review, H1, 2015
Summary
GlobalData's clinical trial report, Uveitis Global Clinical Trials Review, H1, 2015" provides an overview of Uveitis clinical trials scenario. This report provides
top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across
the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas
proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc
across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 6
uveitis 6
report Guidance 6
clinical Trials By Region 7
clinical Trials And Average Enrollment By Country 8
top Five Countries Contributing To Clinical Trials In Asia-pacific 10
top Five Countries Contributing To Clinical Trials In Europe 11
top Countries Contributing To Clinical Trials In North America 12
top Five Countries Contributing To Clinical Trials In Middle East And Africa 13
top Five Countries Contributing To Clinical Trials In Central And South America 14
clinical Trials By G7 Countries: Proportion Of Uveitis To Ophthalmology Clinical Trials 15
clinical Trials By Phase In G7 Countries 16
clinical Trials In G7 Countries By Trial Status 17
clinical Trials By E7 Countries: Proportion Of Uveitis To Ophthalmology Clinical Trials 18
clinical Trials By Phase In E7 Countries 19
clinical Trials In E7 Countries By Trial Status 20
clinical Trials By Phase 21
in Progress Trials By Phase 22
clinical Trials By Trial Status 23
clinical Trials By End Point Status 24
unaccomplished Trials Of Uveitis 25
subjects Recruited Over A Period Of Time 28
Uveitis Global Clinical Trials Review, H1, 2015
clinical Trials By Sponsor Type 29
prominent Sponsors 30
top Companies Participating In Uveitis Therapeutics Clinical Trials 31
prominent Drugs 32
latest Clinical Trials News On Uveitis 33
may 05, 2015: Abbvie Announces Pivotal Phase 3 Data Evaluating Efficacy And Safety Of Humira (adalimumab) In Patients With Non-infectious Intermediate,
Posterior, Or Panuveiti 33
may 05, 2015: Kineta Announces Promising Top-line Clinical Results For Dalazatide; Target Implicated In Broad Array Of Autoimmune Diseases 33
apr 30, 2015: Clearside Biomedical To Report Efficacy And Safety Results In Non-infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone
Acetonide At 2015 Arvo Meeting 35
mar 16, 2015: Clearside Biomedical Reports Efficacy And Safety Results In Non-infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone
Acetonide 35
clinical Trial Profiles 36
clinical Trial Overview Of Top Companies 36
novartis Ag 36
clinical Trial Overview Of Novartis Ag 36
xoma Corporation 38
clinical Trial Overview Of Xoma Corporation 38
valeant Pharmaceuticals International, Inc. 39
clinical Trial Overview Of Valeant Pharmaceuticals International, Inc. 39
f. Hoffmann-la Roche Ltd. 40
clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 40
actavis Plc 41
clinical Trial Overview Of Actavis Plc 41
les Laboratoires Servier Sas 42
clinical Trial Overview Of Les Laboratoires Servier Sas 42
abbvie Inc. 43
clinical Trial Overview Of Abbvie Inc. 43
panacea Biotec Limited 44
clinical Trial Overview Of Panacea Biotec Limited 44
lux Biosciences, Inc. 45
clinical Trial Overview Of Lux Biosciences, Inc. 45
celgene Corporation 46
clinical Trial Overview Of Celgene Corporation 46
clinical Trial Overview Of Top Institutes / Government 47
national Eye Institute 47
clinical Trial Overview Of National Eye Institute 47
moorfields Eye Hospital Nhs Foundation Trust 49
clinical Trial Overview Of Moorfields Eye Hospital Nhs Foundation Trust 49
oregon Health & Science University 50
clinical Trial Overview Of Oregon Health & Science University 50
the Johns Hopkins University 51
clinical Trial Overview Of The Johns Hopkins University 51
university Of California, San Francisco 52
clinical Trial Overview Of University Of California, San Francisco 52
capital Medical University 53
clinical Trial Overview Of Capital Medical University 53
duke University 54
clinical Trial Overview Of Duke University 54
institut De Recherches Internationales Servier 55
clinical Trial Overview Of Institut De Recherches Internationales Servier 55
jhsph Center For Clinical Trials 56
clinical Trial Overview Of Jhsph Center For Clinical Trials 56
rafik Hariri University Hospital 57
clinical Trial Overview Of Rafik Hariri University Hospital 57
five Key Clinical Profiles 58
appendix 98
abbreviations 98
definitions 98
research Methodology 99
secondary Research 99
about Globaldata 100
contact Us 100
disclaimer 100
source 100
list Of Tables
uveitis Therapeutics, Global, Clinical Trials By Region, 2015* 7
Uveitis Global Clinical Trials Review, H1, 2015
uveitis Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2015* 8
uveitis Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2015* 9
uveitis Therapeutics Clinical Trials, Asia-pacific, Top Five Countries, 2015* 10
uveitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
uveitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
uveitis Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries, 2015* 13
uveitis Therapeutics Clinical Trials, Central And South America, Top Five Countries, 2015* 14
proportion Of Uveitis To Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
uveitis Therapeutics, G7 Countries, Clinical Trials By Phase, 2015* 16
uveitis Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2015* 17
proportion Of Uveitis To Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
uveitis Therapeutics, E7 Countries, Clinical Trials By Phase, 2015* 19
uveitis Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2015* 20
uveitis Therapeutics, Global, Clinical Trials By Phase, 2015* 21
uveitis Therapeutics, Global, Clinical Trials In Progress By Phase 2015* 22
uveitis Therapeutics, Global, Clinical Trials By Trial Status, 2015* 23
uveitis Therapeutics Clinical Trials, Global, By End Point Status, 2015* 24
uveitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
uveitis Therapeutics, Global, Terminated Clinical Trials, 2015* 26
uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
uveitis Therapeutics Market, Global, Clinical Trials By Sponsor Type, 2015* 29
uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
uveitis Therapeutics Clinical Trials, Global, Top Companies By Phase, 2015* 31
uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2015* 32
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Novartis Ag, 2015* 36
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Xoma Corporation, 2015* 38
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Valeant Pharmaceuticals International, Inc., 2015* 39
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By F. Hoffmann-la Roche Ltd., 2015* 40
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Actavis Plc, 2015* 41
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Les Laboratoires Servier Sas, 2015* 42
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Abbvie Inc., 2015* 43
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Panacea Biotec Limited, 2015* 44
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Lux Biosciences, Inc., 2015* 45
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Celgene Corporation, 2015* 46
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By National Eye Institute, 2015* 47
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Moorfields Eye Hospital Nhs Foundation Trust, 2015* 49
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Oregon Health & Science University, 2015* 50
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By The Johns Hopkins University, 2015* 51
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of California, San Francisco, 2015* 52
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Capital Medical University, 2015* 53
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Duke University, 2015* 54
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Institut De Recherches Internationales Servier, 2015* 55
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Jhsph Center For Clinical Trials, 2015* 56
uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Rafik Hariri University Hospital, 2015* 57
list Of Figures
uveitis Therapeutics, Global, Clinical Trials By Region (%), 2015* 7
uveitis Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2015* 8
uveitis Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2015* 9
uveitis Therapeutics Clinical Trials, Asia-pacific, Top Five Countries (%), 2015* 10
uveitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
uveitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
uveitis Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries (%), 2015* 13
uveitis Therapeutics Clinical Trials, Central And South America, Top Five Countries (%), 2015* 14
proportion Of Uveitis To Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
uveitis Therapeutics, G7 Countries, Clinical Trials By Phase, 2015* 16
uveitis Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2015* 17
proportion Of Uveitis To Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
uveitis Therapeutics, E7 Countries, Clinical Trials By Phase, 2015* 19
uveitis Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2015* 20
uveitis Therapeutics, Global, Clinical Trials By Phase (%), 2015* 21
uveitis Therapeutics, Global, Clinical Trials In Progress By Phase, 2015* 22
uveitis Therapeutics, Global, Clinical Trials By Trial Status, 2015* 23
uveitis Therapeutics Clinical Trials, Global, By End Point Status, 2015* 24
uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
uveitis Therapeutics Market, Global, Clinical Trials By Sponsor Type (%), 2015* 29
uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
uveitis Therapeutics Clinical Trials, Global, Top Companies By Phase, 2015* 31
Uveitis Global Clinical Trials Review, H1, 2015
uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2015* 32
globaldata Methodology 99
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Uveitis Global Clinical Trials Review, H1, 2015

More Related Content

What's hot

Ulcers global clinical trials review, h1, 2014
Ulcers global clinical trials review, h1, 2014Ulcers global clinical trials review, h1, 2014
Ulcers global clinical trials review, h1, 2014
QYResearchReports
 
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
ReportsnReports
 
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
MedicReS
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
Ann-Marie Roche
 
Kalorama Round Up of AACC Chicago 2014
Kalorama Round Up of AACC Chicago 2014Kalorama Round Up of AACC Chicago 2014
Kalorama Round Up of AACC Chicago 2014
Bruce Carlson
 
Point of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysisPoint of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysis
Renub Research
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
suraj mungase
 
Continuous Manufacturing Regulatory Update
Continuous Manufacturing Regulatory Update Continuous Manufacturing Regulatory Update
Continuous Manufacturing Regulatory Update
Ajaz Hussain
 
Regulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsRegulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging Markets
PAREXEL International
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
JABEEN FATIMA
 
Life Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory StrategyLife Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory Strategy
The Capital Network
 
Pharmacovigilance in local clinical trials
Pharmacovigilance in local clinical trialsPharmacovigilance in local clinical trials
Pharmacovigilance in local clinical trials
idkpharma
 
Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14
GMP EDUCATION : Not for Profit Organization
 
Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1
Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1
Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1
Prajakta Buva
 
Presentation on Risk-Mapp, ADE, PDE, and multi-product facilities
Presentation on Risk-Mapp, ADE, PDE, and multi-product facilitiesPresentation on Risk-Mapp, ADE, PDE, and multi-product facilities
Presentation on Risk-Mapp, ADE, PDE, and multi-product facilities
Dean Calhoun
 
[000012]
[000012][000012]
[000012]
Jatin Nagar
 
Growing a uk cell therapy industry delivering health & wealth, presentation b...
Growing a uk cell therapy industry delivering health & wealth, presentation b...Growing a uk cell therapy industry delivering health & wealth, presentation b...
Growing a uk cell therapy industry delivering health & wealth, presentation b...
Cell and Gene Therapy Catapult
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
Jacobe2008
 
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR
 
2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool
2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool
2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool
Alain van Gool
 

What's hot (20)

Ulcers global clinical trials review, h1, 2014
Ulcers global clinical trials review, h1, 2014Ulcers global clinical trials review, h1, 2014
Ulcers global clinical trials review, h1, 2014
 
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
 
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
 
Kalorama Round Up of AACC Chicago 2014
Kalorama Round Up of AACC Chicago 2014Kalorama Round Up of AACC Chicago 2014
Kalorama Round Up of AACC Chicago 2014
 
Point of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysisPoint of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysis
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
 
Continuous Manufacturing Regulatory Update
Continuous Manufacturing Regulatory Update Continuous Manufacturing Regulatory Update
Continuous Manufacturing Regulatory Update
 
Regulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsRegulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging Markets
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Life Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory StrategyLife Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory Strategy
 
Pharmacovigilance in local clinical trials
Pharmacovigilance in local clinical trialsPharmacovigilance in local clinical trials
Pharmacovigilance in local clinical trials
 
Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14
 
Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1
Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1
Cutter PTCA catheter Regulatory strategy for PMDA submission_12-7-11_FINAL-1
 
Presentation on Risk-Mapp, ADE, PDE, and multi-product facilities
Presentation on Risk-Mapp, ADE, PDE, and multi-product facilitiesPresentation on Risk-Mapp, ADE, PDE, and multi-product facilities
Presentation on Risk-Mapp, ADE, PDE, and multi-product facilities
 
[000012]
[000012][000012]
[000012]
 
Growing a uk cell therapy industry delivering health & wealth, presentation b...
Growing a uk cell therapy industry delivering health & wealth, presentation b...Growing a uk cell therapy industry delivering health & wealth, presentation b...
Growing a uk cell therapy industry delivering health & wealth, presentation b...
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
 
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
 
2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool
2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool
2016 11-17 Oncology by design 2016 course, Amsterdam, Alain van Gool
 

Similar to Uveitis global clinical trials review, h1, 2015

Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
ReportsnReports
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
Ambikabasa
 
Liver Fibrosis Global Clinical Trials Review, H1, 2013
Liver Fibrosis Global Clinical Trials Review, H1, 2013Liver Fibrosis Global Clinical Trials Review, H1, 2013
Liver Fibrosis Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
Ambikabasa
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Diarrhea pipeline review, h1 2015
Diarrhea   pipeline review, h1 2015Diarrhea   pipeline review, h1 2015
Diarrhea pipeline review, h1 2015
Ambikabasa
 
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Congenital Heart Disease Global Clinical Trials Review, H1, 2012
Congenital Heart Disease Global Clinical Trials Review, H1, 2012Congenital Heart Disease Global Clinical Trials Review, H1, 2012
Congenital Heart Disease Global Clinical Trials Review, H1, 2012
ReportLinker.com
 
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
ReportsnReports
 
Filariasis Global Clinical Trials Review, H1, 2013
Filariasis Global Clinical Trials Review, H1, 2013Filariasis Global Clinical Trials Review, H1, 2013
Filariasis Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)
Patrick V. Ulrich
 
Anal Fissure Global Clinical Trials Review, H1, 2013
Anal Fissure Global Clinical Trials Review, H1, 2013Anal Fissure Global Clinical Trials Review, H1, 2013
Anal Fissure Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Series of interview Questions
Series of interview QuestionsSeries of interview Questions
Series of interview Questions
ClinosolIndia
 
JSS Medical Research PACES PMOS HEOR
JSS Medical Research PACES PMOS HEORJSS Medical Research PACES PMOS HEOR
JSS Medical Research PACES PMOS HEOR
MNI08072014
 
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013
ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
ReportLinker.com
 

Similar to Uveitis global clinical trials review, h1, 2015 (20)

Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
 
Liver Fibrosis Global Clinical Trials Review, H1, 2013
Liver Fibrosis Global Clinical Trials Review, H1, 2013Liver Fibrosis Global Clinical Trials Review, H1, 2013
Liver Fibrosis Global Clinical Trials Review, H1, 2013
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013
 
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
 
Diarrhea pipeline review, h1 2015
Diarrhea   pipeline review, h1 2015Diarrhea   pipeline review, h1 2015
Diarrhea pipeline review, h1 2015
 
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013
 
Congenital Heart Disease Global Clinical Trials Review, H1, 2012
Congenital Heart Disease Global Clinical Trials Review, H1, 2012Congenital Heart Disease Global Clinical Trials Review, H1, 2012
Congenital Heart Disease Global Clinical Trials Review, H1, 2012
 
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012
 
Filariasis Global Clinical Trials Review, H1, 2013
Filariasis Global Clinical Trials Review, H1, 2013Filariasis Global Clinical Trials Review, H1, 2013
Filariasis Global Clinical Trials Review, H1, 2013
 
WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)WerfenLife Annual Report (2015)
WerfenLife Annual Report (2015)
 
Anal Fissure Global Clinical Trials Review, H1, 2013
Anal Fissure Global Clinical Trials Review, H1, 2013Anal Fissure Global Clinical Trials Review, H1, 2013
Anal Fissure Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
Series of interview Questions
Series of interview QuestionsSeries of interview Questions
Series of interview Questions
 
JSS Medical Research PACES PMOS HEOR
JSS Medical Research PACES PMOS HEORJSS Medical Research PACES PMOS HEOR
JSS Medical Research PACES PMOS HEOR
 
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 

More from Ambikabasa

Cleco corporation power plants and swot analysis, 2015 update
Cleco corporation   power plants and swot analysis, 2015 updateCleco corporation   power plants and swot analysis, 2015 update
Cleco corporation power plants and swot analysis, 2015 update
Ambikabasa
 
Philippines telecoms, mobile and broadband
Philippines   telecoms, mobile and broadbandPhilippines   telecoms, mobile and broadband
Philippines telecoms, mobile and broadband
Ambikabasa
 
Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015
Ambikabasa
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
Ambikabasa
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
Ambikabasa
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Ambikabasa
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
Ambikabasa
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
Ambikabasa
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
Ambikabasa
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
Ambikabasa
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
Ambikabasa
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
Ambikabasa
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
Ambikabasa
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
Ambikabasa
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
Ambikabasa
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
Ambikabasa
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
Ambikabasa
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
Ambikabasa
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015
Ambikabasa
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
Ambikabasa
 

More from Ambikabasa (20)

Cleco corporation power plants and swot analysis, 2015 update
Cleco corporation   power plants and swot analysis, 2015 updateCleco corporation   power plants and swot analysis, 2015 update
Cleco corporation power plants and swot analysis, 2015 update
 
Philippines telecoms, mobile and broadband
Philippines   telecoms, mobile and broadbandPhilippines   telecoms, mobile and broadband
Philippines telecoms, mobile and broadband
 
Addiction pipeline review, h1 2015
Addiction   pipeline review, h1 2015Addiction   pipeline review, h1 2015
Addiction pipeline review, h1 2015
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 

Recently uploaded

Best Forex Brokers Comparison in INDIA 2024
Best Forex Brokers Comparison in INDIA 2024Best Forex Brokers Comparison in INDIA 2024
Best Forex Brokers Comparison in INDIA 2024
Top Forex Brokers Review
 
Creative Web Design Company in Singapore
Creative Web Design Company in SingaporeCreative Web Design Company in Singapore
Creative Web Design Company in Singapore
techboxsqauremedia
 
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
AnnySerafinaLove
 
Digital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on SustainabilityDigital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on Sustainability
sssourabhsharma
 
Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024
Kirill Klimov
 
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Neil Horowitz
 
Easily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYCEasily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYC
Any kyc Account
 
Income Tax exemption for Start up : Section 80 IAC
Income Tax  exemption for Start up : Section 80 IACIncome Tax  exemption for Start up : Section 80 IAC
Income Tax exemption for Start up : Section 80 IAC
CA Dr. Prithvi Ranjan Parhi
 
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
Stephen Cashman
 
3 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 20243 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 2024
SEOSMMEARTH
 
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
APCO
 
Mastering B2B Payments Webinar from BlueSnap
Mastering B2B Payments Webinar from BlueSnapMastering B2B Payments Webinar from BlueSnap
Mastering B2B Payments Webinar from BlueSnap
Norma Mushkat Gaffin
 
amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05
marketing317746
 
Understanding User Needs and Satisfying Them
Understanding User Needs and Satisfying ThemUnderstanding User Needs and Satisfying Them
Understanding User Needs and Satisfying Them
Aggregage
 
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your TasteZodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
my Pandit
 
Digital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital ExcellenceDigital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital Excellence
Operational Excellence Consulting
 
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdfThe 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
thesiliconleaders
 
Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024
FelixPerez547899
 
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
hartfordclub1
 
Business storytelling: key ingredients to a story
Business storytelling: key ingredients to a storyBusiness storytelling: key ingredients to a story
Business storytelling: key ingredients to a story
Alexandra Fulford
 

Recently uploaded (20)

Best Forex Brokers Comparison in INDIA 2024
Best Forex Brokers Comparison in INDIA 2024Best Forex Brokers Comparison in INDIA 2024
Best Forex Brokers Comparison in INDIA 2024
 
Creative Web Design Company in Singapore
Creative Web Design Company in SingaporeCreative Web Design Company in Singapore
Creative Web Design Company in Singapore
 
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
 
Digital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on SustainabilityDigital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on Sustainability
 
Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024
 
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
 
Easily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYCEasily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYC
 
Income Tax exemption for Start up : Section 80 IAC
Income Tax  exemption for Start up : Section 80 IACIncome Tax  exemption for Start up : Section 80 IAC
Income Tax exemption for Start up : Section 80 IAC
 
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
The Heart of Leadership_ How Emotional Intelligence Drives Business Success B...
 
3 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 20243 Simple Steps To Buy Verified Payoneer Account In 2024
3 Simple Steps To Buy Verified Payoneer Account In 2024
 
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
 
Mastering B2B Payments Webinar from BlueSnap
Mastering B2B Payments Webinar from BlueSnapMastering B2B Payments Webinar from BlueSnap
Mastering B2B Payments Webinar from BlueSnap
 
amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05
 
Understanding User Needs and Satisfying Them
Understanding User Needs and Satisfying ThemUnderstanding User Needs and Satisfying Them
Understanding User Needs and Satisfying Them
 
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your TasteZodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
 
Digital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital ExcellenceDigital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital Excellence
 
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdfThe 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
 
Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024
 
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
 
Business storytelling: key ingredients to a story
Business storytelling: key ingredients to a storyBusiness storytelling: key ingredients to a story
Business storytelling: key ingredients to a story
 

Uveitis global clinical trials review, h1, 2015

  • 1. Uveitis Global Clinical Trials Review, H1, 2015 Uveitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, Uveitis Global Clinical Trials Review, H1, 2015" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 uveitis 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Five Countries Contributing To Clinical Trials In Middle East And Africa 13 top Five Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Uveitis To Ophthalmology Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Uveitis To Ophthalmology Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Uveitis 25 subjects Recruited Over A Period Of Time 28 Uveitis Global Clinical Trials Review, H1, 2015
  • 2. clinical Trials By Sponsor Type 29 prominent Sponsors 30 top Companies Participating In Uveitis Therapeutics Clinical Trials 31 prominent Drugs 32 latest Clinical Trials News On Uveitis 33 may 05, 2015: Abbvie Announces Pivotal Phase 3 Data Evaluating Efficacy And Safety Of Humira (adalimumab) In Patients With Non-infectious Intermediate, Posterior, Or Panuveiti 33 may 05, 2015: Kineta Announces Promising Top-line Clinical Results For Dalazatide; Target Implicated In Broad Array Of Autoimmune Diseases 33 apr 30, 2015: Clearside Biomedical To Report Efficacy And Safety Results In Non-infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone Acetonide At 2015 Arvo Meeting 35 mar 16, 2015: Clearside Biomedical Reports Efficacy And Safety Results In Non-infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone Acetonide 35 clinical Trial Profiles 36 clinical Trial Overview Of Top Companies 36 novartis Ag 36 clinical Trial Overview Of Novartis Ag 36 xoma Corporation 38 clinical Trial Overview Of Xoma Corporation 38 valeant Pharmaceuticals International, Inc. 39 clinical Trial Overview Of Valeant Pharmaceuticals International, Inc. 39 f. Hoffmann-la Roche Ltd. 40 clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 40 actavis Plc 41 clinical Trial Overview Of Actavis Plc 41 les Laboratoires Servier Sas 42 clinical Trial Overview Of Les Laboratoires Servier Sas 42 abbvie Inc. 43 clinical Trial Overview Of Abbvie Inc. 43 panacea Biotec Limited 44 clinical Trial Overview Of Panacea Biotec Limited 44 lux Biosciences, Inc. 45 clinical Trial Overview Of Lux Biosciences, Inc. 45 celgene Corporation 46 clinical Trial Overview Of Celgene Corporation 46 clinical Trial Overview Of Top Institutes / Government 47 national Eye Institute 47 clinical Trial Overview Of National Eye Institute 47 moorfields Eye Hospital Nhs Foundation Trust 49 clinical Trial Overview Of Moorfields Eye Hospital Nhs Foundation Trust 49 oregon Health & Science University 50 clinical Trial Overview Of Oregon Health & Science University 50 the Johns Hopkins University 51 clinical Trial Overview Of The Johns Hopkins University 51 university Of California, San Francisco 52 clinical Trial Overview Of University Of California, San Francisco 52 capital Medical University 53 clinical Trial Overview Of Capital Medical University 53 duke University 54 clinical Trial Overview Of Duke University 54 institut De Recherches Internationales Servier 55 clinical Trial Overview Of Institut De Recherches Internationales Servier 55 jhsph Center For Clinical Trials 56 clinical Trial Overview Of Jhsph Center For Clinical Trials 56 rafik Hariri University Hospital 57 clinical Trial Overview Of Rafik Hariri University Hospital 57 five Key Clinical Profiles 58 appendix 98 abbreviations 98 definitions 98 research Methodology 99 secondary Research 99 about Globaldata 100 contact Us 100 disclaimer 100 source 100 list Of Tables uveitis Therapeutics, Global, Clinical Trials By Region, 2015* 7 Uveitis Global Clinical Trials Review, H1, 2015
  • 3. uveitis Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2015* 8 uveitis Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2015* 9 uveitis Therapeutics Clinical Trials, Asia-pacific, Top Five Countries, 2015* 10 uveitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11 uveitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12 uveitis Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries, 2015* 13 uveitis Therapeutics Clinical Trials, Central And South America, Top Five Countries, 2015* 14 proportion Of Uveitis To Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15 uveitis Therapeutics, G7 Countries, Clinical Trials By Phase, 2015* 16 uveitis Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2015* 17 proportion Of Uveitis To Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18 uveitis Therapeutics, E7 Countries, Clinical Trials By Phase, 2015* 19 uveitis Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2015* 20 uveitis Therapeutics, Global, Clinical Trials By Phase, 2015* 21 uveitis Therapeutics, Global, Clinical Trials In Progress By Phase 2015* 22 uveitis Therapeutics, Global, Clinical Trials By Trial Status, 2015* 23 uveitis Therapeutics Clinical Trials, Global, By End Point Status, 2015* 24 uveitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25 uveitis Therapeutics, Global, Terminated Clinical Trials, 2015* 26 uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28 uveitis Therapeutics Market, Global, Clinical Trials By Sponsor Type, 2015* 29 uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30 uveitis Therapeutics Clinical Trials, Global, Top Companies By Phase, 2015* 31 uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2015* 32 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Novartis Ag, 2015* 36 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Xoma Corporation, 2015* 38 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Valeant Pharmaceuticals International, Inc., 2015* 39 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By F. Hoffmann-la Roche Ltd., 2015* 40 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Actavis Plc, 2015* 41 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Les Laboratoires Servier Sas, 2015* 42 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Abbvie Inc., 2015* 43 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Panacea Biotec Limited, 2015* 44 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Lux Biosciences, Inc., 2015* 45 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Celgene Corporation, 2015* 46 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By National Eye Institute, 2015* 47 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Moorfields Eye Hospital Nhs Foundation Trust, 2015* 49 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Oregon Health & Science University, 2015* 50 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By The Johns Hopkins University, 2015* 51 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of California, San Francisco, 2015* 52 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Capital Medical University, 2015* 53 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Duke University, 2015* 54 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Institut De Recherches Internationales Servier, 2015* 55 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Jhsph Center For Clinical Trials, 2015* 56 uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials By Rafik Hariri University Hospital, 2015* 57 list Of Figures uveitis Therapeutics, Global, Clinical Trials By Region (%), 2015* 7 uveitis Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2015* 8 uveitis Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2015* 9 uveitis Therapeutics Clinical Trials, Asia-pacific, Top Five Countries (%), 2015* 10 uveitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11 uveitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12 uveitis Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries (%), 2015* 13 uveitis Therapeutics Clinical Trials, Central And South America, Top Five Countries (%), 2015* 14 proportion Of Uveitis To Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15 uveitis Therapeutics, G7 Countries, Clinical Trials By Phase, 2015* 16 uveitis Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2015* 17 proportion Of Uveitis To Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18 uveitis Therapeutics, E7 Countries, Clinical Trials By Phase, 2015* 19 uveitis Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2015* 20 uveitis Therapeutics, Global, Clinical Trials By Phase (%), 2015* 21 uveitis Therapeutics, Global, Clinical Trials In Progress By Phase, 2015* 22 uveitis Therapeutics, Global, Clinical Trials By Trial Status, 2015* 23 uveitis Therapeutics Clinical Trials, Global, By End Point Status, 2015* 24 uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28 uveitis Therapeutics Market, Global, Clinical Trials By Sponsor Type (%), 2015* 29 uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30 uveitis Therapeutics Clinical Trials, Global, Top Companies By Phase, 2015* 31 Uveitis Global Clinical Trials Review, H1, 2015
  • 4. uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2015* 32 globaldata Methodology 99 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: Sales Team, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Uveitis Global Clinical Trials Review, H1, 2015